Lung cancer remains one of the deadliest cancers worldwide, with survival rates stubbornly low despite advances in surgery, ...
News-Medical.Net on MSN
Small molecule AVJ16 shows promise in targeting lung cancer growth
Researchers have discovered a promising new approach to lung cancer treatment. A small molecule called AVJ16 selectively blocks the cancer-driving protein IGF2BP1, halting tumor growth in preclinical ...
The FANSS shows a 1.3% lung cancer detection rate among 1000 Asian women with no smoking history, which is comparable to ...
Researchers have found that patients with interstitial lung disease (ILD) are at greatly heightened risk of developing all ...
Lung cancer screening guidelines do not exist for individuals who never smoked, but data presented at International ...
A team led by Christian Baumgartner of the Institute of Health Care Engineering at Graz University of Technology (TU Graz) ...
Machine learning models can help predict which patients receiving systemic therapy for non-small lung cancer are most likely ...
Huntsman Cancer Institute's Discovery Innovations showcase the latest advances in cancer treatment, research, and prevention. These achievements demonstrate the progress being made in ending cancer as ...
In December 2024, the FDA granted accelerated approval to BIZENGRI (Merus) for adult patients with advanced, unresectable, or ...
Early trial results report progression-free survival and response rates for ateganosine, spevatamig, Annamycin and pumitamig; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback